166 related articles for article (PubMed ID: 36769265)
1. The Relationship between Serum miRNAs and Early Mortality in Multiple Myeloma Patients Treated with Bortezomib-Based Regimens.
Puła A; Robak P; Jarych D; Mikulski D; Misiewicz M; Drozdz I; Fendler W; Szemraj J; Robak T
Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769265
[TBL] [Abstract][Full Text] [Related]
2. Circulating serum microRNAs as biomarkers of drug resistance in multiple myeloma patients treated with bortezomib-based regimens - pilot study.
Puła A; Robak T; Dróżdż I; Stawiski K; Rycerz A; Misiewicz M; Robak P
Leuk Lymphoma; 2024 Feb; 65(2):257-264. PubMed ID: 37948578
[TBL] [Abstract][Full Text] [Related]
3. The Value of Serum MicroRNA Expression Signature in Predicting Refractoriness to Bortezomib-Based Therapy in Multiple Myeloma Patients.
Robak P; Dróżdż I; Jarych D; Mikulski D; Węgłowska E; Siemieniuk-Ryś M; Misiewicz M; Stawiski K; Fendler W; Szemraj J; Smolewski P; Robak T
Cancers (Basel); 2020 Sep; 12(9):. PubMed ID: 32916955
[TBL] [Abstract][Full Text] [Related]
4. Low serum miR-19a expression as a novel poor prognostic indicator in multiple myeloma.
Hao M; Zang M; Wendlandt E; Xu Y; An G; Gong D; Li F; Qi F; Zhang Y; Yang Y; Zhan F; Qiu L
Int J Cancer; 2015 Apr; 136(8):1835-44. PubMed ID: 25220540
[TBL] [Abstract][Full Text] [Related]
5. Serum microRNA array analysis identifies miR-140-3p, miR-33b-3p and miR-671-3p as potential osteoarthritis biomarkers involved in metabolic processes.
Ntoumou E; Tzetis M; Braoudaki M; Lambrou G; Poulou M; Malizos K; Stefanou N; Anastasopoulou L; Tsezou A
Clin Epigenetics; 2017; 9():127. PubMed ID: 29255496
[TBL] [Abstract][Full Text] [Related]
6. Circulating miRNAs as diagnostic biomarkers for multiple myeloma and monoclonal gammopathy of undetermined significance.
Li J; Zhang M; Wang C
J Clin Lab Anal; 2020 Jun; 34(6):e23233. PubMed ID: 32039495
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of hsa_circ_0003489 shifts balance from autophagy to apoptosis and sensitizes multiple myeloma cells to bortezomib via miR-874-3p/HDAC1 axis.
Tian FQ; Chen ZR; Zhu W; Tang MQ; Li JH; Zhang XC; Jiang J; Cheng XH
J Gene Med; 2021 Sep; 23(9):e3329. PubMed ID: 33625798
[TBL] [Abstract][Full Text] [Related]
8. Lncrna ANGPTL1-3 and its target microRNA-30a exhibit potency as biomarkers for bortezomib response and prognosis in multiple myeloma patients.
Zhou F; Guo L
Hematology; 2022 Dec; 27(1):596-602. PubMed ID: 35617291
[TBL] [Abstract][Full Text] [Related]
9. Identification of non-invasive biomarkers for chronic atrophic gastritis from serum exosomal microRNAs.
Liu H; Li PW; Yang WQ; Mi H; Pan JL; Huang YC; Hou ZK; Hou QK; Luo Q; Liu FB
BMC Cancer; 2019 Feb; 19(1):129. PubMed ID: 30736753
[TBL] [Abstract][Full Text] [Related]
10. A Panel of MicroRNA Signature as a Tool for Predicting Survival of Patients with Urothelial Carcinoma of the Bladder.
Inamoto T; Uehara H; Akao Y; Ibuki N; Komura K; Takahara K; Takai T; Uchimoto T; Saito K; Tanda N; Yoshikawa Y; Minami K; Hirano H; Nomi H; Kato R; Hayashi T; Azuma H
Dis Markers; 2018; 2018():5468672. PubMed ID: 30026881
[TBL] [Abstract][Full Text] [Related]
11. Potential role of exosome-associated microRNA panels and in vivo environment to predict drug resistance for patients with multiple myeloma.
Zhang L; Pan L; Xiang B; Zhu H; Wu Y; Chen M; Guan P; Zou X; Valencia CA; Dong B; Li J; Xie L; Ma H; Wang F; Dong T; Shuai X; Niu T; Liu T
Oncotarget; 2016 May; 7(21):30876-91. PubMed ID: 27129167
[TBL] [Abstract][Full Text] [Related]
12. Circulating microRNAs as biomarkers of adult Crohn's disease.
Jensen MD; Andersen RF; Christensen H; Nathan T; Kjeldsen J; Madsen JS
Eur J Gastroenterol Hepatol; 2015 Sep; 27(9):1038-44. PubMed ID: 26230660
[TBL] [Abstract][Full Text] [Related]
13. Serum outperforms plasma in small extracellular vesicle microRNA biomarker studies of adenocarcinoma of the esophagus.
Chiam K; Mayne GC; Wang T; Watson DI; Irvine TS; Bright T; Smith LT; Ball IA; Bowen JM; Keefe DM; Thompson SK; Hussey DJ
World J Gastroenterol; 2020 May; 26(20):2570-2583. PubMed ID: 32523312
[TBL] [Abstract][Full Text] [Related]
14. Circulating Serum MiRNA-8074 as a Novel Prognostic Biomarker for Multiple Myeloma.
Szudy-Szczyrek A; Mlak R; Mielnik M; Mazurek M; Chocholska S; Podgajna M; Szczyrek M; Homa-Mlak I; Małecka-Massalska T; Hus M
Cells; 2022 Feb; 11(4):. PubMed ID: 35203396
[TBL] [Abstract][Full Text] [Related]
15. Atrophic gastritis and gastric cancer tissue miRNome analysis reveals hsa-miR-129-1 and hsa-miR-196a as potential early diagnostic biomarkers.
Varkalaite G; Vaitkeviciute E; Inciuraite R; Salteniene V; Juzenas S; Petkevicius V; Gudaityte R; Mickevicius A; Link A; Kupcinskas L; Leja M; Kupcinskas J; Skieceviciene J
World J Gastroenterol; 2022 Feb; 28(6):653-663. PubMed ID: 35317427
[TBL] [Abstract][Full Text] [Related]
16. Construction of a Diagnostic Model for Distinguishing Benign or Malignant Bone Cancer by Mining miRNA Expression Data.
Zhang Y; Hu J; Li T; Hao S; Wu X
Biochem Genet; 2023 Feb; 61(1):299-315. PubMed ID: 35861903
[TBL] [Abstract][Full Text] [Related]
17. A 9-microRNA Signature in Serum Serves as a Noninvasive Biomarker in Early Diagnosis of Alzheimer's Disease.
Guo R; Fan G; Zhang J; Wu C; Du Y; Ye H; Li Z; Wang L; Zhang Z; Zhang L; Zhao Y; Lu Z
J Alzheimers Dis; 2017; 60(4):1365-1377. PubMed ID: 29036818
[TBL] [Abstract][Full Text] [Related]
18. [Circulating Serum MicroRNA as Diagnostic Biomarkers for Multiple Myeloma].
Xu YN; Xiao CR; Huang YD; Lu QY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Apr; 25(2):471-475. PubMed ID: 28446295
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA Derived from Circulating Exosomes as Noninvasive Biomarkers for Diagnosing Renal Cell Carcinoma.
Xiao CT; Lai WJ; Zhu WA; Wang H
Onco Targets Ther; 2020; 13():10765-10774. PubMed ID: 33122915
[TBL] [Abstract][Full Text] [Related]
20. microRNAs as the biomarkers of chemotherapy-induced peripheral neuropathy in patients with multiple myeloma.
Łuczkowska K; Rogińska D; Ulańczyk Z; Safranow K; Paczkowska E; Baumert B; Milczarek S; Osękowska B; Górska M; Borowiecka E; Sommerfeld K; Zawodny P; Szudy-Szczyrek A; Hus M; Machaliński B
Leuk Lymphoma; 2021 Nov; 62(11):2768-2776. PubMed ID: 34092168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
